| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 3.9 | $0-$5k | 0.00 |
Summary
A vulnerability marked as problematic has been reported in TeamPass up to 2.1.5. Affected is an unknown function. This manipulation of the argument Login causes cross site scripting. This vulnerability is handled as CVE-2012-2234. The attack can be initiated remotely. Additionally, an exploit exists. It is suggested to upgrade the affected component.
Details
A vulnerability was found in TeamPass up to 2.1.5. It has been declared as problematic. Affected by this vulnerability is an unknown code. The manipulation of the argument login with an unknown input leads to a cross site scripting vulnerability. The CWE definition for the vulnerability is CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. As an impact it is known to affect integrity. The summary by CVE is:
Cross-site scripting (XSS) vulnerability in sources/users.queries.php in TeamPass before 2.1.6 allows remote authenticated users to inject arbitrary web script or HTML via the login parameter in an add_new_user action.
The weakness was released 04/21/2012 by Marcos Garcia (Website). It is possible to read the advisory at github.com. This vulnerability is known as CVE-2012-2234 since 04/13/2012. The attack can be launched remotely. The exploitation doesn't need any form of authentication. It demands that the victim is doing some kind of user interaction. Technical details and also a public exploit are known. The attack technique deployed by this issue is T1059.007 according to MITRE ATT&CK.
It is possible to download the exploit at packetstormsecurity.com. It is declared as proof-of-concept.
Upgrading to version 2.1.2 eliminates this vulnerability.
The vulnerability is also documented in the databases at Exploit-DB (37087), SecurityFocus (BID 53038†) and OSVDB (81197†). Be aware that VulDB is the high quality source for vulnerability data.
Product
Name
Version
License
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 3.9
VulDB Base Score: 4.3
VulDB Temp Score: 3.9
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Access: Public
Status: Proof-of-Concept
Download: 🔍
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Exploit-DB: 🔍
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Upgrade: TeamPass 2.1.2
Timeline
04/13/2012 🔍04/17/2012 🔍
04/21/2012 🔍
04/21/2012 🔍
03/23/2015 🔍
04/30/2025 🔍
Sources
Advisory: github.comResearcher: Marcos Garcia
Status: Confirmed
CVE: CVE-2012-2234 (🔍)
GCVE (CVE): GCVE-0-2012-2234
GCVE (VulDB): GCVE-100-60631
X-Force: 74910
SecurityFocus: 53038 - TeamPass 'login' Field HTML Injection Vulnerability
OSVDB: 81197
scip Labs: https://www.scip.ch/en/?labs.20161013
Entry
Created: 03/23/2015 16:50Updated: 04/30/2025 14:15
Changes: 03/23/2015 16:50 (48), 02/16/2019 15:32 (5), 12/01/2021 11:38 (3), 12/01/2021 11:46 (1), 06/30/2024 01:26 (23), 04/30/2025 14:15 (3)
Complete: 🔍
Cache ID: 216::103
Be aware that VulDB is the high quality source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.